{"slideshow_credits": null, "snippet": "Known as T-DM1, the drug delayed the progression of cancer by three months in a late-stage clinical trial of 991 women with metastatic breast cancer.", "abstract": "Investigators report the drug T-DM1, developed by Genentech, delayed the progression of cancer by three months in a late-stage clinical trial of 991 women with metastatic breast cancer; drug lacks some side effects of traditional treatments and appears to substantially prolong lives.", "section_name": "Health", "print_page": "23", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/06/03/health/research/in-study-drug-delays-worsening-of-breast-cancer-with-fewer-side-effects.html", "lead_paragraph": "Known as T-DM1, the drug delayed the progression of cancer by three months in a late-stage clinical trial of 991 women with metastatic breast cancer.", "headline": {"main": "In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects", "print_headline": "In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects"}, "_id": "53f76b1638f0d835538dbd3c", "word_count": "989", "multimedia": [], "pub_date": "2012-06-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Breast Cancer", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Herceptin (Drug)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Research", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Genentech Inc", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "ImmunoGen Inc", "name": "organizations", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "Research", "type_of_material": "News"}